Cowen & Co. Initiates Coverage On Better Therapeutics with Outperform Rating

Cowen & Co. analyst Charles Rhyee initiates coverage on Better Therapeutics (NASDAQ:BTTX) with a Outperform rating.

Cowen & Co. analyst Charles Rhyee initiates coverage on Better Therapeutics (NASDAQ:BTTX) with a Outperform rating.

Total
0
Shares
Related Posts